Investigational drug may improve stem cell transplantation for multiple myeloma patients (IMAGE)
Caption
Shown are multiple myeloma cells from a patient. An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis has shown that the investigational drug motixafortide — when combined with the standard therapy for mobilizing stem cells — significantly increased the number of stem cells that can be harvested, compared with treatment with the standard agent alone. If approved, the combination with motixafortide potentially would improve stem cell transplantation for multiple myeloma patients.
Credit
MARIANNA RUZINOVA
Usage Restrictions
None
License
Original content